Interaction between N6-methyladenosine modification and the tumor microenvironment in colorectal cancer

Abstract The incidence and mortality of colorectal cancer (CRC) are rapidly increasing worldwide. Recently, there has been significant attention given to N6-methyladenosine (m6A), the most common mRNA modification, especially for its effects on CRC development. It is important to note that the progr...

Full description

Bibliographic Details
Main Authors: Jiali Yao, Yeke Song, Xiaoping Yu, Zhijie Lin
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Molecular Medicine
Subjects:
Online Access:https://doi.org/10.1186/s10020-023-00726-2
_version_ 1827710493540745216
author Jiali Yao
Yeke Song
Xiaoping Yu
Zhijie Lin
author_facet Jiali Yao
Yeke Song
Xiaoping Yu
Zhijie Lin
author_sort Jiali Yao
collection DOAJ
description Abstract The incidence and mortality of colorectal cancer (CRC) are rapidly increasing worldwide. Recently, there has been significant attention given to N6-methyladenosine (m6A), the most common mRNA modification, especially for its effects on CRC development. It is important to note that the progression of CRC would be greatly hindered without the tumor microenvironment (TME). The interaction between CRC cells and their surroundings can activate and influence complex signaling mechanisms of epigenetic changes to affect the survival of tumor cells with a malignant phenotype. Additionally, the TME is influenced by m6A regulatory factors, impacting the progression and prognosis of CRC. In this review, we describe the interactions and specific mechanisms between m6A modification and the metabolic, hypoxia, inflammatory, and immune microenvironments of CRC. Furthermore, we summarize the therapeutic role that m6A modification can play in the CRC microenvironment, and discuss the current status, limitations, and potential future directions in this field. This review aims to provide new insights into the molecular targets and theoretical foundations for the treatment of CRC.
first_indexed 2024-03-10T17:38:49Z
format Article
id doaj.art-9a3f62395b7d4c80b406e0c4c164ca99
institution Directory Open Access Journal
issn 1528-3658
language English
last_indexed 2024-03-10T17:38:49Z
publishDate 2023-09-01
publisher BMC
record_format Article
series Molecular Medicine
spelling doaj.art-9a3f62395b7d4c80b406e0c4c164ca992023-11-20T09:46:14ZengBMCMolecular Medicine1528-36582023-09-0129111510.1186/s10020-023-00726-2Interaction between N6-methyladenosine modification and the tumor microenvironment in colorectal cancerJiali Yao0Yeke Song1Xiaoping Yu2Zhijie Lin3Department of Immunology, Institute of Translational Medicine, Medical College, Yangzhou UniversityDepartment of Immunology, Institute of Translational Medicine, Medical College, Yangzhou UniversityHealth Management Center, Affiliated Hospital of Yangzhou University, Yangzhou UniversityDepartment of Immunology, Institute of Translational Medicine, Medical College, Yangzhou UniversityAbstract The incidence and mortality of colorectal cancer (CRC) are rapidly increasing worldwide. Recently, there has been significant attention given to N6-methyladenosine (m6A), the most common mRNA modification, especially for its effects on CRC development. It is important to note that the progression of CRC would be greatly hindered without the tumor microenvironment (TME). The interaction between CRC cells and their surroundings can activate and influence complex signaling mechanisms of epigenetic changes to affect the survival of tumor cells with a malignant phenotype. Additionally, the TME is influenced by m6A regulatory factors, impacting the progression and prognosis of CRC. In this review, we describe the interactions and specific mechanisms between m6A modification and the metabolic, hypoxia, inflammatory, and immune microenvironments of CRC. Furthermore, we summarize the therapeutic role that m6A modification can play in the CRC microenvironment, and discuss the current status, limitations, and potential future directions in this field. This review aims to provide new insights into the molecular targets and theoretical foundations for the treatment of CRC.https://doi.org/10.1186/s10020-023-00726-2Colorectal cancerm6ATumor microenvironment
spellingShingle Jiali Yao
Yeke Song
Xiaoping Yu
Zhijie Lin
Interaction between N6-methyladenosine modification and the tumor microenvironment in colorectal cancer
Molecular Medicine
Colorectal cancer
m6A
Tumor microenvironment
title Interaction between N6-methyladenosine modification and the tumor microenvironment in colorectal cancer
title_full Interaction between N6-methyladenosine modification and the tumor microenvironment in colorectal cancer
title_fullStr Interaction between N6-methyladenosine modification and the tumor microenvironment in colorectal cancer
title_full_unstemmed Interaction between N6-methyladenosine modification and the tumor microenvironment in colorectal cancer
title_short Interaction between N6-methyladenosine modification and the tumor microenvironment in colorectal cancer
title_sort interaction between n6 methyladenosine modification and the tumor microenvironment in colorectal cancer
topic Colorectal cancer
m6A
Tumor microenvironment
url https://doi.org/10.1186/s10020-023-00726-2
work_keys_str_mv AT jialiyao interactionbetweenn6methyladenosinemodificationandthetumormicroenvironmentincolorectalcancer
AT yekesong interactionbetweenn6methyladenosinemodificationandthetumormicroenvironmentincolorectalcancer
AT xiaopingyu interactionbetweenn6methyladenosinemodificationandthetumormicroenvironmentincolorectalcancer
AT zhijielin interactionbetweenn6methyladenosinemodificationandthetumormicroenvironmentincolorectalcancer